Sentinel Lymph Node Biopsy in Breast Cancer

Surgical Oncology Clinics of North America

Volumn 17, Issue 3, 2008, Pages 673-699

  Fortunato, Lucio ^a   Mascaro, Alessandra ^a   Amini, Mostafa ^a   Farina, Massimo ^a   Vitelli, Carlo Eugenio ^a  

^a SAN GIOVANNI ADDOLORATA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT CHEMOTHERAPY; BREAST CANCER; CANCER STAGING; CANCER SURVIVAL; CARCINOMA IN SITU; CLINICAL STUDY; ECHOGRAPHY; HEMATOMA; HISTOPATHOLOGY; HUMAN; INCIDENCE; INJECTION SITE; LABORATORY DIAGNOSIS; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPHEDEMA; MASTECTOMY; MICROMETASTASIS; MORBIDITY; MULTIPLE CANCER; PARESTHESIA; PATIENT MONITORING; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PROGNOSIS; RANGE OF MOTION; RECURRENT CANCER; REPEAT PROCEDURE; REVIEW; RISK FACTOR; SEGMENTAL MASTECTOMY; SENTINEL LYMPH NODE; SEROMA; TREATMENT CONTRAINDICATION; TREATMENT PLANNING; TUMOR VOLUME; WOUND INFECTION;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; HUMANS; INTRAOPERATIVE PERIOD; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

EID: 43449083186     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soc.2008.03.001     Document Type: Review

References (170)

1. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
2. Harris J.R., Lippman M.E., Veronesi U., et al. Breast cancer. N Engl J Med 327 (1992) 473-480
3. Fisher B., Bauer M., Wickerham D.L., et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: an NSABP update. Cancer 52 (1983) 1551-1557
4. Gould E.A., Winship T., Philbin P.H., et al. Observations on a "sentinel node" in cancer of the parotid. Cancer 13 (1960) 77-78
5. Cabanas R.M. An approach for the treatment of penile carcinoma. Cancer 39 (1997) 456-466
6. Morton D.L., Wen D.R., Wong J.H., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 127 (1992) 392-399
7. Giuliano A.E., Kirgan D.M., Guenther J.M., et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 220 (1994) 391-398
8. Albertini J.J., Lyman G.H., Cox C., et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 276 (1996) 1818-1822
9. Tafra L. The learning curve and sentinel node biopsy. Am J Surg 182 (2001) 347-350
10. Cox C.E., Salud C.J., Cantor A., et al. Learning curves for breast cancer sentinel lymph node mapping based on surgical volume analysis. J Am Coll Surg 192 (2001) 9-16
11. Chagpar A.B., Martin R.C., Scoggins C.R., et al. Factors predicting failure to identify a sentinel lymph node in breast cancer. Surgery 138 (2005) 56-63
12. Kern K.A. Lymphoscintigraphic anatomy of sentinel lymphatic channels after subareolar injection of technetium 99 sulfur colloid. J Am Coll Surg 193 (2001) 601-608
13. Nathanson S.D., Wachna D.L., Gilman D., et al. Pathways of lymphatic drainage from the breast. Ann Surg Oncol 8 (2001) 837-843
14. Povoski S.P., Olsen J.O., Young D.C., et al. Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel lymph node mapping and biopsy in breast cancer. Ann Surg Oncol 13 (2006) 1412-1421
15. Rodier J.F., Velten M., Wilt M., et al. Prospective multicentric randomized study comparing periareolar and peritumoral injection of radiotracer and blue dye for the detection of sentinel lymph node in breast sparing procedure: FRANSENODE trial. J Clin Oncol 25 (2007) 3664-3669
16. Chagpar A., Martin R.C., Chao C., et al. Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Arch Surg 139 (2004) 614-620
17. Chagpar A.B., Carlson D.J., Laidley A.L., et al. Factors influencing the number of sentinel lymph nodes identified in patients with breast cancer. Am J Surg 194 (2007) 860-864
18. McMasters K.M., Wong S.L., Chao C., et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node (SLN) biopsy. A model for implementation of new surgical technique. Ann Surg 234 (2001) 292-300
19. Nathanson S.D., Grogan J.K., DeBruyn D., et al. Breast cancer lymph node identification rates: influence of radiocolloid mapping, case volume, and the place of the procedure. Ann Surg Oncol 14 (2007) 1629-1637
20. Derossis A.M., Fey J., Young H., et al. A trend analysis of the relative value of the blue dye and isotope localization in 2000 consecutive cases of sentinel node biopsy for breast cancer. J Am Coll Surg 193 (2001) 473-478
21. Kim T., Giuliano A.E., and Lyman G.H. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma. Cancer 106 (2006) 4-16
22. Krag DN, Anderson SJ, Julian TB, et al. Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8 (2007) 881-888
23. Tafra L., Lannin D.R., Swanson M.S., et al. Multicenter trial of sentinel lymph node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue. Ann Surg 233 (2001) 51-59
24. Cody H.S., Hill A.D.K., Tran K.N., et al. Credentialing for breast lymphatic mapping: how many cases are enough?. Ann Surg 229 (1999) 723-728
25. Veronesi U., Paganelli G., Viale G., et al. Sentinel lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7 (2006) 983-990
26. Barone J.E., Tucker J.B., Perez J.M., et al. Evidence-based medicine applied to sentinel lymph node biopsy in patients with breast cancer. Am Surg 71 (2005) 66-70
27. Naik A.M., Fey J., Gemignani M., et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 240 (2004) 462-468
28. Veronesi U., Galimberti V., Mariani L., et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer 41 (2005) 231-237
29. Veronesi U., Paganelli G., and Viale G. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349 (2003) 546-553
30. Krag D.N., Julian T.B., Harlow S.P., et al. NSABP-32: phase III randomized trial comparing axillary resection with sentinel lymph node dissection. A description of the trial. Ann Surg Oncol 11 Suppl 3 (2004) 208S-210S
31. Clarke D., Khonji N.I., and Mansel R.E. Sentinel node biopsy in breast cancer: ALMANAC trial. World J Surg 25 (2001) 819-822
32. Sakorafas G.H., Perso G., Cataliotti L., et al. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 15 (2006) 153-165
33. Wilke L.G., McCall L.M., Posther K.E., et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13 (2006) 491-500
34. Burak W.E., Hollenbeck S.T., Zervos E.E., et al. Sentinel lymph node biopsy results in less post-operatibe morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 183 (2002) 23-27
35. Schulze T., Markwardt J., Schlag P., et al. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol 93 (2006) 109-119
36. Baron R.H., Fey J.V., Borgen P.I., et al. Eighteen sensation after breast cancer surgery: a 5-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Ann Surg Oncol 14 (2007) 1653-1661
37. Del Bianco P., Zavagno G., Burelli P., et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. EJSO (2007) [Epub ahead of print]
38. Purushotam A.D., Upponi S., Klevesath M.B., et al. Morbidity after sentinel lymph node biopsy in primary breast cancer. Results from a randomized controlled trial. J Clin Oncol 23 (2005) 4312-4321
39. Fleissig A., Fallowfield L.J., Langridge C.I., et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomized trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95 (2006) 279-293
40. Fortunato L., Amini M., Farina M., et al. Intraoperative examination of sentinel nodes in breast cancer: Is the glass half full or half empty?. Ann Surg Oncol 11 (2004) 1005-1010
41. Attebery M.L., Sielig B.A., Ciocca R., et al. Touch prep cytology as a preferred approach for sentinel lymph nodes in breast cancer. Breast J 13 (2007) 106-107
42. Jeruss J.S., Hunt K.K., Xing Y., et al. Is intraoperative touch imprint cytology of sentinel lymph nodes in patients with breast cancer cost effective?. Cancer 107 (2006) 2328-2336
43. Wilke L.G., and Giuliano A. Sentinel lymph node biopsy in patients with early stage breast cancer: status of the National Clinical Trials. Surg Clin North Am 83 (2003) 901-910
44. Grube B.J., and Giuliano A.E. Observation of the breast cancer patient with a tumor-positive sentinel node: implications of the ACOSOG Z0011 trial. Semin Surg Oncol 20 (2001) 230-237
45. Harlow S.P., and Krag D.N. Sentinel lymph node-why study it: implications of the B-32 study. Semin Surg Oncol 20 (2001) 224-229
46. van Diest P.J., Torrenga H., Borgstein P.J., et al. Reliability of intraoperative frozen section and imprint cytological investigation of sentinel lymph nodes in breast cancer. Histopathology 35 (1999) 14-18
47. Smidt M.L., Besseling R., Wauters C.A., et al. Intraoperative scrape cytology of the sentinel lymph node in patients with breast cancer. Br J Surg 89 (2002) 1290-1293
48. Salem A.A., Douglas-Jones A.G., Sweetland H.M., et al. Intraoperative evaluation of axillary sentinel lymph nodes using touch imprint cytology and immunohistochemistry: a protocol of rapid immunostaining of touch imprints. EJSO 29 (2003) 25-28
49. Nahrig J.M., Richter T., Kuhn W., et al. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry. Breast J 9 (2003) 277-281
50. Veronesi U., Zurrida S., Mazzarol G., et al. Extensive frozen section examination of axillary sentinel nodes to determine selective axillary dissection. World J Surg 25 (2001) 806-808
51. Motomura K., Inaji H., Komoike Y., et al. Intraoperative sentinel lymph node examination by imprint cytology and frozen sectioning during breast surgery. Br J Surg 87 (2000) 597-601
52. Menes T.S., Tatter P.I., Mizrachi H., et al. Touch preparation or frozen section of sentinel lymph node metastases from breast cancer. Ann Surg Oncol 10 (2003) 1166-1170
53. Aihara T., Munakata S., Morino H., et al. Comparison of frozen section and touch imprint cytology for evaluation of sentinel lymph node metastasis in breast cancer. Ann Surg Oncol 11 (2004) 747-750
54. Tew K., Irwig L., Matthews A., et al. Meta-analysis of sentinel node imprint cytology in breast cancer. Br J Surg 92 (2005) 1068-1080
55. Weiser M.R., Montgomery L.L., Susnik B., et al. Is routine intraoperative frozen-section examination of sentinel lymph nodes in breast cancer worthwhile?. Ann Surg Oncol 45 (2000) 185-190
56. Shiver S.A., Creager A.J., Geisinger K., et al. Intraoperative analysis of sentinel lymph nodes by imprint cytology for cancer of the breast. Am J Surg 184 (2002) 424-427
57. Fitzgibbons P.L., Connolly J.L., and Page D.L. Updated protocol for the examination of specimens from patients with carcinomas of the breast. Cancer Committee. Arch Pathol Lab Med 12 (2000) 1027-1033
58. Schwartz G.F., Giuliano A.E., and Veronesi U. Consensus Conference Committee. Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast April 19-22, 2001, Philadelphia, Pennsylvania. Hum Pathol 33 (2002) 579-589
59. Perry N., Broeders M., de Wolf C., et al. European guidelines for quality assurance in breast cancer screening and diagnosis. 4th edition (2006), European Communities, Luxembourg (Luxembourg)
60. Forza Operativa Nazionale Cancro della Mammella (FONCAM). Linee guida sul linfonodo sentinella nel cancro della mammella. Available at:. http://www.societaitalianasenologia.it/pdf%20nuovo/anatomia%20patologica.pdf Accessed December 1, 2007
61. Pathology reporting on breast disease. NHS cancer screening programmes (2005), NHSBSP publication 58, Sheffield (UK). http://www.cancerscreening.nhs.uk/breastscreen/publications/nhsbsp58-low-resolution.pdf Accessed December 1, 2007
62. Kuehn T., Bembenek A., Decker T., et al. A concept for the clinical implementation of sentinel lymph node biopsy in patients with breast carcinoma with special regards to quality assurance. Cancer 103 (2005) 451-461
63. Sentinel-Lymphknotenbiopsien. Available at:. http://www.pathology.at/sentinel.htm Accessed December 1, 2007
64. Australian Cancer Network Breast Pathology Working Party. The pathology reporting of breast cancer. A guide for pathologists, surgeons, radiologists and oncologists. 2nd edition. ACN Publication n 7. Sidney (Australia). Australian Cancer Network. 2001. Available at: http://www.cancer.org.au/documents/The_Pathology_reporting-of-breast-cancer-2001.pdf. Accessed December 1, 2007.
65. Cserni G., Amendoeira I., Apostolikas N., et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire-based survey by the European Working Group for Breast Screening Pathology. J Clin Pathol 57 (2005) 695-701
66. Bolster M.J., Bult P., Schapers R.F.M., et al. Differences in sentinel lymph node pathology protocols lead to differences in surgical strategy in breast cancer patients. Ann Surg Oncol 13 (2006) 1466-1473
67. Giuliano A.E., Dale P.S., Turner R.R., et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 180 (1995) 700-704
68. van Rijk M.C., Deterse J.L., Nieweg O.E., et al. Additional axillary metastases and stage migration in breast cancer patients with micrometastases or submicrometastases in sentinel lymph nodes. Cancer 107 (2006) 467-471
69. Fortunato L., Drago S., Vitelli C.E., et al. Il linfonodo sentinella nel cancro della mammella: results of the Rome Breast Cancer Study Group. Chir Ital 58 (2006) 689-696
70. Cserni G. Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients. J Clin Pathol 55 (2002) 926-931
71. Torrenga H., Rahusen F.D., Meijer S., et al. Sentinel node investigation in breast cancer: detailed analysis of the yield from step sectioning and immunohistochemistry. J Clin Pathol 54 (2001) 550-552
72. Turner R.R., Ollila D.W., Stern S., et al. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 23 (1999) 263-267
73. Freneaux P., Nos C., Vincent-Salomon A., et al. Histological detection of minimal metastatic involvement in axillary sentinel nodes: a rational basis for a sensitive methodology usable in daily practice. Mod Pathol 15 (2002) 641-646
74. Fortunato L., Amini M., Costarelli L., et al. A standardized sentinel lymph node enhanced pathology protocol (SEPP) in patients with breast cancer. J Surg Oncol 96 (2007) 470-473
75. Joslyn S.A., and Konety B.R. Effect of axillary lymphadenectomy on breast cancer survival. Breast Cancer Res Treat 91 (2005) 11-18
76. Orr R.K. The impact of prophylactic axillary node dissection on breast cancer survival: a Bayesian meta-analysis. Ann Surg Oncol 6 (1999) 109-116
77. Carter C.L., Allen C., Henson D.C., et al. Relation of tumor size, lymph node status and survival in 24740 breast cancer cases. Cancer 63 (1989) 181-187
78. Cserni G., Gregori D., Merletti F., et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br J Cancer 91 (2004) 1245-1252
79. Fortunato L., Amini M., Farina M., et al. Sentinel lymph node metastases in patients with breast cancer: axillary dissection or observation?. Osp Ital Chir 13 (2005) 693-697
80. Van Zee K., Manasseh D.M.E., Bevilacqua J.L.B., et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 10 (2003) 1140-1151
81. Chagpar A.B., Scoggins C.R., and Martin R.C. Prediction of sentinel lymph node-only disease in women with invasive cancer. Am J Surg 192 (2006) 882-887
82. Bolster M.J., Peer P.G., Bult P., et al. Risk factors for non-sentinel lymph node metastases in patients with breast cancer: the outcome of a multi-institutional study. Ann Surg Oncol 14 (2006) 181-189
83. Turner R.R., Chu K.U., Qi K., et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 89 (2000) 574-581
84. Hwang D., Krishamurthy S., Hunt K.K., et al. Clinicopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 10 (2003) 248-253
85. Barranger E., Coutant C., Flahault A., et al. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res Treat 91 (2005) 113-119
86. Alran S., De Rycke Y.D., Fourchotte V., et al. Validation and limitations of the use of a breast cancer nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy. Ann Surg Oncol 14 (2007) 2195-2201
87. Parks J., Fey J.V., Naik A.N., et al. A declining rate of axillary dissection in sentinel lymph node-positive breast cancer patients is associated with the use of a multivariate nomogram. Ann Surg 245 (2007) 462-468
88. Rutgers E.J., Meijnen P., and Bonnefoi H. European Organization for Research and Treatment of Cancer: Clinical trials update of the European Organization for Research and Treatment of Cancer Breast Cancer Group. Breast Cancer Res 6 (2004) 165-169
89. Samoilova E., Davis J.T., Hinson J., et al. Lymph node involvement: which breast cancer patients may benefit from less aggressive axillary dissection?. Ann Surg Oncol 14 (2007) 2221-2227
90. Cronin-Fenton D.P., Ries L.A., Clegg L.X., et al. Rising incidence rates of breast carcinoma with micrometastatic lymph node involvement. J Natl Cancer Inst 99 (2007) 1044-1049
91. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet 335 (1990) 1565-1568
92. Dowlatshahi K., Fan M., Snider H.C., et al. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 80 (1997) 1188-1197
93. Tan L.K., Giri D., Panageas K., et al. Occult micrometastases in axillary lymph nodes of breast cancer patients are significant: a retrospective study with long-term follow-up (abstract). Proc Am Soc Clin Oncol 21 (2002) 37
94. Colleoni M., Rotmensz N., Peruzzotti G., et al. Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol 23 (2005) 1379-1389
95. National Cancer Institute, US National Institute of Health clinical trials. International Breast Cancer Study Group (IBCSG). Galiberti V Trial 23-01. Phase III randomized study of surgical resection with or without axillary lymph node dissection in women with a clinically node-negative breast cancer with a sentinel micrometastasis. Available at: (2004). http://www.cancer.gov/clinicaltrials/IBCSG23-01 Accessed December 1, 2007
96. White Jr. R.L., and Wilke L.G. Update on the NSABP and ACOSOG breast cancer sentinel node trials. Am Surg 70 (2004) 420-424
97. Leonard G.D., and Swain S.M. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 96 (2004) 906-920
98. van Deurzen C.H.M., Hobbelink M.G.G., van Hillegersberg R., et al. Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review. Eur J Cancer 43 (2007) 993-1001
99. Zavagno G., Carcoforo P., Marconato R., et al. Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast. BMC Cancer 5 (2005) 28
100. Veronesi P., Intra M., Vento A.R., et al. Sentinel lymph node biopsy for localized ductal carcinoma in situ?. Breast 14 (2005) 520-522
101. Cody S.H. Sentinel lymph node biopsy for DCIS: are we approaching consensus?. Ann Surg Oncol 12 (2007) 2179-2181
102. Moore K.H., Sweeney K.J., Wilson M.E., et al. Outcomes for women with ductal carcinoma in-situ and a positive sentinel node: a multi institutional audit. Ann Surg Oncol 14 (2007) 2911-2917
103. Broekhuizen L.N., Wijsman J.H., Peterse J.L., et al. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast. Eur J Surg Oncol 32 (2006) 502-506
104. Klauber-DeMore N., Tan L.K., Liberman L., et al. Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?. Ann Surg Oncol 7 (2000) 636-642
105. Jimenez R.E., and Visscher D.W. Clinicopathologic analysis of microscopically invasive breast carcinoma. Hum Pathol 29 (1998) 1412-1419
106. Zavotsky J., Hansen N., Brennan M.B., et al. Lymph node metastasis from ductal carcinoma in situ with microinvasion. Cancer 85 (1999) 2439-2443
107. Intra M., Zurrida S., Maffini F., et al. Sentinel lymph node metastases in microinvasive breast cancer. Ann Surg Oncol 10 (2003) 1160-1165
108. Zavagno G., Belardinelli V., Marconato R., et al. Sentinel lymph node metastasis from mammary ductal carcinoma in situ with microinvasion. Breast 16 (2007) 146-151
109. Fortunato L, Santoni M, Drago S, et al. Sentinel lymph node biopsy in women with pT1a or "micro-invasive" breast cancer. The Breast, in press.
110. Sl W., Chao C., Edwards M.J., et al. Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancer. Am Surg 67 (2001) 522-526
111. Coombs N., Chen W., Taylor R., et al. A decision tool for predicting sentinel node accuracy from breast tumor size and grade. Breast J 13 (2007) 593-598
112. Bedrosian I., Reynolds C., Mick R., et al. Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors. Cancer 88 (2000) 2540-2545
113. Olson J.A., Fey J., Winaver J., et al. Sentinel lymphadenectomy accurately predicts nodal status in T2 breast cancer. J Am Coll Surg 191 (2000) 593-599
114. Chung M.H., Ye W., and Giuliano A.E. Role of sentinel lymph node dissection in the management of large (>5 cm) invasive breast cancer. Ann Surg Oncol 8 (2001) 688-692
115. Lelievre L., Houvenaeghel G., Buttarelli M., et al. Value of sentinel lymph node procedure in patients with large size breast cancer. Ann Surg Oncol 14 (2006) 621-626
116. Schule J., Frisell J., Ingvar C., et al. Sentinel node biopsy for breast cancer larger than 3 cm in diameter. Br J Surg 94 (2007) 948-951
117. Schrenk P., and Wayand W. Sentinel-node biopsy in axillary lymph node staging for patients with multicentric breast cancer. Lancet 357 (2001) 122
118. Fernandez K., Swanson M., Verbanac K., et al. Is sentinel lymphadenectomy accurate in multifocal and multicentric breast cancer?. [abstract 29]. Proceedings of the 55th Annual Cancer Symposium of the Society of Surgical Oncology (2002) S9-S16
119. Kumar R., Jana S., Heiba S.I., et al. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable or non palpable breast cancer. J Nucl Med 44 (2003) 7-10
120. Tousimis E., Van Zee K.J., Fey J.V., et al. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. J Am Coll Surg 197 (2003) 529-535
121. Goyal A., Newcombe R.G., and Mansel R.E. Sentinel lymph node biopsy in patients with multifocal breast cancer. Eur J Surg Oncol 30 (2004) 475-479
122. Knauer M., Konstantiniuk P., Haid A., et al. Multicentric breast cancer: a new indication for sentinel node biopsy-a multi-institutional validation study. J Clin Oncol 24 (2006) 3374-3380
123. Ferrari A., Dionigi P., Rovera F., et al. Multifocality and multicentricity are not contraindications for sentinel lymph node biopsy in breast cancer surgery. World J Surg Oncol 4 (2006) 79-86
124. Gentilini O., Trifirò G., Soteldo J., et al. Sentinel lymph node biopsy in multicentric breast cancer. The experience of the European Institute of Oncology. Ann Surg Oncol 32 (2006) 507-510
125. D'Eredita G., Giardina C., Ingravallo G., et al. Sentinel lymph node biopsy in multiple breast cancer using subareolar injection of the tracer. Breast 16 (2007) 316-322
126. Breslin T.M., Cohen L.F., Sahin A., et al. Sentinel lymph node biopsy is accurate after neoadjuvant chemotherapy for breast cancer. J Clin Oncol 18 (2000) 3480-3484
127. Tafra L., Verbanac K.M., and Lannin D.R. Preoperative chemotherapy and sentinel lymphadenectomy for breast cancer. Am J Surg 182 (2001) 312-315
128. Fernandez A., Cortes M., Benito E., et al. Gamma probe sentinel node localization and biopsy in breast cancer patients treated with a neoadjuvant chemotherapy scheme. Nucl Med Commun 22 (2001) 361-366
129. Julian T.B., Dusi D., and Wolmark N. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer. Am J Surg 184 (2002) 315-317
130. Stearns V., Ewing C.A., Slack R., et al. Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Ann Surg Oncol 9 (2002) 235-242
131. Brady E.W. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer. Breast J 8 (2002) 97-100
132. Schwartz G.F., and Meltzer A.J. Accuracy of axillary sentinel lymph node biopsy following neoadjuvant (induction) chemotherapy for carcinoma of the breast. Breast J 9 (2003) 374-379
133. Piato J.R., Barros A.C., Pincerato K.M., et al. Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. Eur J Surg Oncol 29 (2003) 118-120
134. Reitsamer R., Peintinger F., Rettenbacher L., et al. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy. J Surg Oncol 84 (2003) 63-67
135. Kang S.H., Kim S.K., Kwon Y., et al. Decreased identification rate of sentinel lymph node after neoadjuvant chemotherapy. World J Surg 28 (2004) 1019-1024
136. Lang J.E., Esserman L.J., Ewing C.A., et al. Accuracy of sentinel lymphadenectomy after neoadjuvant chemotherapy: effect of clinical node status at presentation. J Am Coll Surg 199 (2004) 856-862
137. Shimazu K., Tamaki Y., Taguchi T., et al. Sentinel lymph node biopsy using periareolar injection of radiocolloid for patients with neoadjuvant chemotherapy-treated breast carcinoma. Cancer 100 (2004) 2555-2561
138. Balch G.C., Mithani S.K., Richards K.R., et al. Lymphatic mapping and sentinel lymphadenectomy after preoperative therapy for stage II and III breast cancer. Ann Surg Oncol 10 (2003) 616-621
139. Aihara T., Munakata S., Morino H., et al. Feasibility of sentinel node biopsy for breast cancer after neoadjuvant endocrine therapy: a pilot study. J Surg Oncol 85 (2004) 77-81
140. Mamounas E.P., Brown A., Anderson S., et al. Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 23 (2005) 2694-2702 Erratum in: J Clin Oncol. 2005;23:4808
141. Tausch C., Konstantiniuk P., Kugler F., et al. Sentinel lymph node biopsy after preoperative chemotherapy for breast cancer: findings from the Austrian Sentinel Node Study Group. Ann Surg Oncol (2006 May 24) (Epub ahead of print)
142. Shen J., Gilcrease M.Z., Babiera G.V., et al. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases. Cancer 109 (2007) 1255-1263
143. Newman E.A., Sabel M.S., Nees A.V., et al. Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation. Ann Surg Oncol 14 (2007) 2946-2952
144. Kinoshita T. Sentinel lymph node biopsy is feasible for breast cancer patients after neoadjuvant chemotherapy. Breast Cancer 14 (2007) 10-15
145. Xing Y., Foy M., Cox D.D., et al. Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer. Br J Surg 93 (2006) 539-546
146. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
147. Veronesi U., Marubini E., Del Vecchio M., et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst 87 (1995) 19-27
148. Roumen R.M.H., Kuijy G.P., and Liem L.H. Lymphatic mapping and sentinel node harvesting in patients with recurrent breast cancer. Eur J Surg Oncol 32 (2006) 1076-1081
149. Sood A., Youssef I.M., Heiba S.I., et al. Alternative lymphatic pathway after previous axillary node dissection in recurrent/primary breast cancer. Clin Nucl Med 29 (2004) 698-702
150. Agarwal A., Heron D.E., Sumkin J., et al. Contralateral uptake and metastases in sentinel lymph node mapping for recurrent breast cancer. J Surg Oncol 92 (2005) 4-8
151. Newman E.A., Cimmino V.M., Sabel M.S., et al. Lymphatic mapping and sentinel lymph node biopsy for patients with local recurrence after breast-conservation therapy. Ann Surg Oncol 13 (2006) 52-57
152. Taback B., Nguyen P., Hansen N., et al. Sentinel lymph node biopsy for local recurrence of breast cancer after breast-conserving therapy. Ann Surg Oncol 13 (2006) 1099-1104
153. Intra M., Trifiro G., Galimberti V., et al. Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence. Br J Surg 94 (2007) 1216-1219
154. Port E.R., Garcia-Etienne C.A., Park J., et al. Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence. Ann Surg Oncol 14 (2007) 2209-2214
155. Barone J.L., Feldman S.M., Estabrook A., et al. Reoperative sentinel lymph node biopsy in patients with locally recurrent breast cancer. Am J Surg 194 (2007) 491-493
156. Axelsson C.K., and Jønsson P.E. Sentinel lymph node biopsy in operations for recurrent breast cancer. Eur J Surg Oncol (2007 Oct 26) (Epub ahead of print)
157. Nori J., Vanzi E., Bazzocchi M., et al. Role of axillary ultrasound in the selection of breast cancer patients for sentinel node biopsy. Am J Surg 193 (2007) 16-20
158. Bonnema J., van Geel A.N., van Ooijen B., et al. Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: new diagnostic method. World J Surg 21 (1997) 270-274
159. Kanter A.Y., van Eijck C.H., van Geel A.N., et al. Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer. Br J Surg 86 (1999) 1459-1462
160. Sato K., Tamaki K., Tsuda H., et al. Utility of axillary ultrasound examination to select breast cancer patients suited of optimal sentinel node biopsy. Am J Surg 187 (2004) 679-683
161. Deurloo E.E., Tanis P.J., Gilhujis K.G.A., et al. Reduction in the number of sentinel lymph node procedures by pre-operative ultrasonography of the axilla in breast cancer. Eur J Cancer 39 (2003) 1068-1073
162. Kuenen-Boumeester V., Menke-Pluymers M., de Kanter A.Y., et al. Ultrasound-guided fine needle aspiration cytology of axillary lymph nodes in breast cancer. A pre-operative staging procedure. Eur J Cancer 39 (2003) 170-174
163. Veronesi U., Marubini E., Mariani L., et al. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomized trial. Eur J Cancer 35 (1999) 1320-1325
164. Estourgie S.H., Nieweg O.E., Valdes Olmos R.A., et al. Lymphatic drainage patterns from the breast. Ann Surg 239 (2004) 232-237
165. Turner-Warwick R.T. The lymphatics of the breast. Br J Surg 46 (1959) 574-582
166. Park C., Sied P., Morita E., et al. Internal mammary sentinel lymph node mapping for invasive breast cancer: implications for staging and treatment. Breast J 11 (2005) 29-33
167. Paganelli G., Galimberti V., Trifirò G., et al. Internal mammary node lymphoscintigraphy and biopsy in breast cancer. Q J Nucl Med 46 (2002) 138-144
168. Galimberti V., Veronesi P., Arnone P., et al. Stage migration after biopsy of internal mammary chain lymph nodes in breast cancer patients. Ann Surg Oncol 9 (2002) 924-928
169. Farrus B., Vidal-Sicart S., Velasco M., et al. Incidence of internal mammary node metastases after a sentinel lymph node technique in breast cancer and its implication in the radiotherapy plan. Int J Radiat Oncol Biol Phys 60 (2004) 715-721
170. Carcoforo P., Sortini D., Feggi L., et al. Clinical and therapeutic importance of sentinel node biopsy of the internal mammary chain in patients with breast cancer: a single-center study with long-term follow-up. Ann Surg Oncol 13 (2006) 1338-1343